Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2005 | 2 |
2010 | 1 |
2012 | 1 |
2013 | 1 |
2018 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Development of Paroxetine Hydrochloride Single Layer Controlled-Release Tablets Based on 3² Factorial Design.
Pharmaceutics. 2018 Nov 20;10(4):243. doi: 10.3390/pharmaceutics10040243.
Pharmaceutics. 2018.
PMID: 30463329
Free PMC article.
However, the complicated double-layer production of PAXIL() CR faces the risk of layer separation. In this study, PHH enteric coating single layer controlled-release tablets (PHH-EC-SLTs) were designed as a simplified substitution of PAXIL() CR through …
However, the complicated double-layer production of PAXIL() CR faces the risk of layer separation. In this study, PHH enteric …
Manufacturing violations prompt seizure of Paxil CR, Avandamet.
[No authors listed]
[No authors listed]
FDA Consum. 2005 May-Jun;39(3):4-5.
FDA Consum. 2005.
PMID: 16130202
Free article.
No abstract available.
Item in Clipboard
Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder.
Sheehan DV, Burnham DB, Iyengar MK, Perera P; Paxil CR Panic Disorder Study Group.
Sheehan DV, et al.
J Clin Psychiatry. 2005 Jan;66(1):34-40.
J Clin Psychiatry. 2005.
PMID: 15669886
Clinical Trial.
Item in Clipboard
Accelerated repetitive transcranial magnetic stimulation for treatment-resistant depression.
Holtzheimer PE 3rd, McDonald WM, Mufti M, Kelley ME, Quinn S, Corso G, Epstein CM.
Holtzheimer PE 3rd, et al.
Depress Anxiety. 2010 Oct;27(10):960-3. doi: 10.1002/da.20731.
Depress Anxiety. 2010.
PMID: 20734360
Free PMC article.
Clinical Trial.
Item in Clipboard
Development and comparative evaluation of in vitro, in vivo properties of novel controlled release compositions of paroxetine hydrochloride hemihydrate as against Geomatrix™ platform technology.
Khatavkar UN, Shimpi SL, Jayaram Kumar K, Deo KD.
Khatavkar UN, et al.
Drug Dev Ind Pharm. 2013 Aug;39(8):1175-86. doi: 10.3109/03639045.2012.682222. Epub 2012 May 21.
Drug Dev Ind Pharm. 2013.
PMID: 22607046
The objective of this study is to develop, in vitro and in vivo evaluation of novel approaches for controlled release of paroxetine hydrochloride hemihydrate (PHH) in comparison to patented formulation PAXIL CR() tablets of GlaxoSmithKline (Geomatrix technology). In …
The objective of this study is to develop, in vitro and in vivo evaluation of novel approaches for controlled release of paroxetine hydrochl …
Item in Clipboard
Cite
Cite